• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
AVCJ
  • North Asia

Japan's MedVenture closes second fund at $95m

  • Justin Niessner
  • 03 December 2020
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  

MedVenture Partners, a Japanese VC firm focused on medical devices, has closed its second fund with JPY9.9 billion ($95 million) in commitments.

LPs include Development Bank of Japan, Fukoku Mutual Life Insurance Company, Shizuoka Bank, Japan Lifeline Co, JMS, Tanaka Kikinzoku Kogyo, Nihon Kohden Corporation, Zeon Medical, Hamamatsu Iwata Shinkin Bank, Sekisui Chemical, and the Organization for Small & Medium Enterprises and Regional Innovation Japan.

MedVenture’s first fund closed at JPY6 billion in 2013. It has invested in 12 companies to date, of which four have been acquired by large medical device corporations.

The follow-up, known as MPI-2, has made eight investments to date both in Japan and overseas and achieved one exit with the sale of US insulin pen maker Companion Medical to global player Medtronic. Much of the plan involves bridging Japanese life sciences companies with overseas device start-ups.

MedVenture claims that Japan has a JPY950 billion trade deficit in medical devices, with therapeutic medical devices accounting for half of that.

“Many of the top therapeutic medical device manufacturers worldwide actively acquire start-up companies to expand their product portfolio and strengthen their position within the market. The development of a similar ecosystem in Japan is vital for the continued growth of the Japanese medical device market,” the firm said in a statement.

Recent activity by MPI-2 includes a seed-stage commitment in March to Tokyo-based Alivas, which develops devices for the treatment of chronic constipation, a condition said to impact 14% of the general population. MedVenture invested alongside DBJ Capital, a VC subsidiary of Development Bank of Japan.

Medical devices have steadily declined as an investment destination in recent years due to industry consolidation and increasing complications around regulatory hurdles, and commercialization processes. Specialist investors have continued to find value, however, in the potential to serve massive markets with relatively underdeveloped innovation ecosystems.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  
  • Topics
  • North Asia
  • Fundraising
  • Venture
  • Healthcare
  • Technology
  • Japan
  • The Development Bank of Japan (DBJ)
  • Organization for Small & Medium Enterprises and Regional Innovation, Japan (SMRJ)

More on North Asia

layerx
Japan's LayerX extends Series A to $67.5m
  • North Asia
  • 09 Nov 2023
integral-office
Integral makes partial exit from Japan’s Skymark
  • North Asia
  • 09 Nov 2023
jean-eric-salata-baring-2019
Q&A: BPEA EQT’s Jean Eric Salata
  • GPs
  • 08 Nov 2023
airport-travel
Asia’s LP landscape: North to south
  • LPs
  • 08 Nov 2023

Latest News

world-hands-globe-climate-esg
Asian GPs slow implementation of ESG policies - survey

Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...

  • GPs
  • 10 November 2023
housing-house-home-mortgage
Singapore fintech start-up LXA gets $10m seed round

New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.

  • Southeast Asia
  • 10 November 2023
india-rupee-money-nbfc
India's InCred announces $60m round, claims unicorn status

Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”

  • South Asia
  • 10 November 2023
roller-mark-luke-finn
Insight leads $50m round for Australia's Roller

Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.

  • Australasia
  • 10 November 2023
Back to Top
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013